Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab

BACKGROUND: Randomized controlled trials and retrospective studies in ANCA-associated vasculitis (AAV) concurred that rituximab (RTX) is effective to induce and maintain remission. Infections and hypogammaglobulinemia during RTX were usually infrequent and uncomplicated. But in the Tromsø study coho...

Descripción completa

Detalles Bibliográficos
Autor principal: Besada, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702309/
https://www.ncbi.nlm.nih.gov/pubmed/26738559
http://dx.doi.org/10.1186/s12891-015-0860-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702309/
https://www.ncbi.nlm.nih.gov/pubmed/26738559
http://dx.doi.org/10.1186/s12891-015-0860-3

Ejemplares similares